Sivec Biotechnologies
Business Services · Colorado, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1505 W Mulberry St, Fort Collins, Colora...Website
www.sivecbiotechnologies.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Sivec Biotechnologies
SiVEC is a biotechnology company focused on revolutionizing therapeutic delivery through its innovative BactPac platform. This platform utilizes engineered bacteria to deliver therapeutic payloads such as mRNA, siRNA, proteins, and CRISPR/Cas to targeted tissues with precision. SiVEC aims to address the challenges faced by pharmaceutical companies in translating therapies from research to clinical application, offering a safe and effective solution for nucleic acid and gene therapies. With a commitment to advancing modern medicine, SiVEC is dedicated to transforming health outcomes through its groundbreaking technology.Explore more
Popular SearchesSiVEC Biotechnologies LLCSiVEC BiotechnologiesSivec Transport LLCSivecbiotechnologiesSIC Code 87,873NAICS Code 54,541Show more
Sivec Biotechnologies Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Sivec Biotechnologies your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Sivec Biotechnologies
Check if Sivec Biotechnologies has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Check out if Sivec Biotechnologies is spiking on competitors!
Earning: See what the market has to say on Sivec Biotechnologies recently announced quarterly report
Product Launch: Get notified when Sivec Biotechnologies launches new products
Funding: Get notified immidiatlly once Sivec Biotechnologies has new funding data
Click to see if Sivec Biotechnologies had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Sivec Biotechnologies, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Sivec Biotechnologies
Compare insights from companies similar to Sivec Biotechnologies, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Sivec Biotechnologies is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Sivec Biotechnologies is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Sivec Biotechnologies.
Sivec Biotechnologies financials insights
Gather financial insights about Sivec Biotechnologies, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Stock/Share Issuance
$3.3M
Sivec Biotechnologies Tech Stack
A closer look at the technologies used by Sivec Biotechnologies
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Sivec Biotechnologies
Sign Up For FreeTo access detailed company insights
SiVEC is a biotechnology company focused on revolutionizing therapeutic delivery through its innovative BactPac platform. This platform utilizes engineered bacteria to deliver therapeutic payloads such as mRNA, siRNA, proteins, and CRISPR/Cas to targeted tissues with precision. SiVEC aims to address the challenges faced by pharmaceutical companies... Read More
